Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

9.7%

7 terminated/withdrawn out of 72 trials

Success Rate

89.2%

+2.7% vs industry average

Late-Stage Pipeline

17%

12 trials in Phase 3/4

Results Transparency

40%

23 of 58 completed trials have results

Key Signals

3 recruiting23 with results6 terminated

Enrollment Performance

Analytics

Phase 2

26(36.6%)

Phase 1

18(25.4%)

N/A

15(21.1%)

Phase 3

12(16.9%)

71Total

Phase 2(26)

Phase 1(18)

N/A(15)

Phase 3(12)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (72)

Showing 20 of 72 trials

NCT06239480Phase 3Active Not Recruiting

SELVA: A Phase 3 Study Evaluating QTORIN 3.9% Rapamycin Anhydrous Gel in the Treatment of Microcystic Lymphatic Malformations

Role: collaborator

NCT06080074Phase 2Recruiting

Multicenter Trial of ECMO in Children With Severe Cardiac Failure Using the Cardiohelp System

Role: collaborator

NCT06552416Phase 1Recruiting

Safety of MT-401-OTS in Patients With Relapsed AML or MDS

Role: collaborator

NCT01743131Phase 2Completed

Abatacept as GVHD Prophylaxis Phase 2

Role: collaborator

NCT06529731Phase 2Recruiting

Interferon-γ (IFN-γ) With Donor Leukocyte Infusion to Treat Relapsed Acute Myeloid Leukemia and Myelodysplastic Syndromes Post Allogeneic Hematopoietic Stem Cell Transplantation

Role: collaborator

NCT00583804Not ApplicableActive Not Recruiting

Implanted Myoelectric Control for Restoration of Hand Function in Spinal Cord Injury

Role: collaborator

NCT04170348Phase 2Completed

Daily Vitamin D for Sickle-cell Respiratory Complications

Role: collaborator

NCT00457639Phase 2Completed

Cholic Acid for Hepatic Steatosis in Lipodystrophy

Role: collaborator

NCT00614666Phase 1Terminated

Safety and PK of Nikkomycin Z for Coccidioides Pneumonia Treatment

Role: collaborator

NCT00429364Phase 3Completed

Comparison of Two Medications Aimed at Slowing Aortic Root Enlargement in Individuals With Marfan Syndrome

Role: collaborator

NCT00414648Phase 3Completed

Efficacy and Safety of Sirolimus in LAM

Role: collaborator

NCT00142051Phase 2Terminated

Inhaled Nitric Oxide for Pediatric Painful Sickle Crisis

Role: collaborator

NCT00004494Phase 1Completed

Phase I Study of Vasoactive Intestinal Peptide in Patients With Acute Respiratory Distress Syndrome and Sepsis

Role: collaborator

NCT02471911Phase 1Completed

KPT-330 Plus RICE for Relapsed/Refractory Aggressive B-Cell Lymphoma

Role: collaborator

NCT00794508Phase 2Completed

MND-ADA Transduction of CD34+ Cells From Children With ADA-SCID

Role: collaborator

NCT00125788Phase 2Completed

L-Glutamine Therapy for Sickle Cell Anemia and Sickle ß0 Thalassemia

Role: collaborator

NCT01488513Phase 1Completed

ABC294640 in Treating Patients With Advanced Solid Tumors

Role: collaborator

NCT00920075Completed

Alendronate in Juvenile Osteoporosis

Role: collaborator

NCT00730236Phase 3Completed

A Safety and Efficacy Study of AEGR-733 to Treat Homozygous Familial Hypercholesterolemia (FH)

Role: collaborator

NCT00650858Phase 2Completed

Clinical Trial on Treatment of Intraventricular Hemorrhage

Role: collaborator